| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |